T2DM patients with ß-cell insufficiency (in old age or with a long history of type 2 diabetes mellitus) or with a longer use of SGLT2 inhibitors may be at higher risk of ketoacidosis (17, 19). This evidence concerns the gene SLC5A2 and diabetes mellitus.